ÂÜÀòÂÒÂ×

Amanda Donovan is an accomplished professional in the field of research and development, currently serving as the Director of Research and Development for Upstream Development at Curium Pharma since March 2018, following roles as Associate Director in both Upstream Development and Analytical Chemistry. Prior to joining Curium Pharma, Amanda held various positions at Jubilant Radiopharma from October 2008 to March 2018, including Manager of Research and Development for Radioactive Products. Amanda's career began at McMaster University, where as a Graduate Student from April 2002 to February 2010, Amanda earned a PhD in Chemistry.